We are live on ! Find out more
HQL

abrdn Life Sciences Investors

52 hedge funds and large institutions have $61.8M invested in abrdn Life Sciences Investors in 2015 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 22 increasing their positions, 13 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 5

69% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 13

9% more capital invested

Capital invested by funds: $56.7M → $61.8M (+$5.06M)

8% more funds holding

Funds holding: 4852 (+4)

0.53% more ownership

Funds ownership: 13.01%13.53% (+0.53%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
52
Holders Change
+4
Holders Change %
+8.33%
% of All Funds
1.36%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
9
Increased
22
Reduced
13
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
CFN
51
Cordasco Financial Network
Florida
-$32K -1,401 Closed
SF
52
Synovus Financial
Georgia
-$26.3K -1,060 Closed
JWA
53
JFS Wealth Advisors
Pennsylvania
+$74 +3 New
Northwestern Mutual Wealth Management
54
Northwestern Mutual Wealth Management
Wisconsin
+$99 +4 New

HQL Hedge Fund Activity: Q4 2015 in Review

52 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q4 2015, worth a combined $61.8M — up 8.9% from $56.7M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new HQL positions and 5 closed out — a net gain of 4 holders — while 22 added to existing stakes and 13 trimmed.

The largest buyer was Bank of Nova Scotia, opening a new position worth an estimated $2.1M. The largest seller was Citigroup, cutting an estimated $677K.

  • 52 institutional investors held abrdn Life Sciences Investors (HQL) as of Q4 2015, up from 48 in Q3 2015.
  • Funds reported $61.8M of abrdn Life Sciences Investors stock for Q4 2015, up 8.9% quarter-over-quarter.
  • 9 funds opened new abrdn Life Sciences Investors positions in Q4 2015 and 5 closed out, a net change of +4 holders.
  • The largest abrdn Life Sciences Investors buyer in Q4 2015 was Bank of Nova Scotia, an estimated $2.1M added.
  • The largest abrdn Life Sciences Investors seller in Q4 2015 was Citigroup, an estimated $677K sold.

Based on aggregated 13F filings for Q4 2015.